No definition available.
Inflammatory disorders of male genital organs, not elsewhere classified
EFO MESH Endpoint Browser PheWeb
N14_INFLAMALEGEN
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
497 |
4. Check minimum number of eventsNone |
497 |
5. Include endpointsNone |
497 |
6. Filter based on genotype QC (FinnGen only) |
497 |
Control definitions (FinnGen only)
- Control exclude
- N14_MALEGEN
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- N40-N51
- Name in latin
- Morbositates inflammatoriae organorum genitalium masculinorum non alibi classificatae
Inflammatory disorders of male genital organs, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4288 | - | 4288 |
| Only index persons | 3668 | - | 3668 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | - | 0.12 |
| Only index persons | 0.14 | - | 0.14 |
| Median age at first event (years) | |||
| Whole population | - | - | 48.29 |
| Only index persons | - | - | 45.88 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 497 | - | 497 |
| Unadjusted period prevalence (%) | 0.22 | - | 0.22 |
| Median age at first event (years) | 54.10 | - | 54.10 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 448
- Matched controls
- 4479
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N49.2
ICD-10 Finland
Inflammatory disorders of scrotum
3156.5
204.5
182
*
N49.9
ICD-10 Finland
Inflammatory disorder of unspecified male genital organ
+∞
178.4
159
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
45.9
72.9
89
24
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
96.6
60.8
66
8
KFA40
NOMESCO Finland
Incision of scrotum
280.6
50.1
50
*
N40
ICD-10 Finland
Hyperplasia of prostate
6.4
46.8
140
296
6084A
ICD-9 Finland
Other disorders of male genital organs, Other inflammatory disorders of male genital organs
+∞
41.3
39
*
KED22
NOMESCO Finland
Transurethral resection of prostate
27.6
33.0
45
18
J01MA02
ATC
ciprofloxacin; systemic
3.5
32.2
216
947
QBA10
NOMESCO Finland
Incision of skin of trunk
36.4
31.5
40
12
N45.0
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis with abscess
+∞
29.5
28
*
60750
ICD-8 Finland
Other disease of male genital organs, Other inflammatory diseases
+∞
28.4
27
*
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
28.6
27.5
37
14
UKC02
NOMESCO Finland
Cystoscopy
4.6
26.2
100
262
XKD00
NOMESCO Finland
Uroflowmetry
4.4
24.8
99
270
KGH10
NOMESCO Finland
Operation for phimosis
49.6
23.6
28
6
N49.1
ICD-10 Finland
Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens
+∞
23.1
22
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
11.8
22.7
42
39
KFD20
NOMESCO Finland
Excision of hydrocele of testis
+∞
22.1
21
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.9
21.6
98
299
N49.0
ICD-10 Finland
Inflammatory disorders of seminal vesicle
+∞
21.0
20
*
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
31.8
20.8
27
9
R33
ICD-10 Finland
Retention of urine
5.6
19.9
60
120
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.0
18.1
78
225
KFA00
NOMESCO Finland
Exploration of testis
187.1
17.6
18
*
N43.3
ICD-10 Finland
Hydrocele, unspecified
30.2
17.6
23
8
J01MA12
ATC
levofloxacin; systemic
3.0
16.1
102
395
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.9
15.9
54
123
G04CA02
ATC
tamsulosin; oral
2.5
15.9
154
770
L73.2
ICD-10 Finland
Hidradenitis suppurativa
34.8
15.9
20
6
J01FF01
ATC
clindamycin; systemic
2.6
15.4
139
667
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
15.3
134
628
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.0
15.1
63
176
N30.0
ICD-10 Finland
Acute cystitis
5.9
14.6
41
75
P01AB01
ATC
metronidazole; oral, rectal
2.4
14.6
152
781
J01EA01
ATC
trimethoprim; systemic
3.9
14.5
63
182
J01DB01
ATC
cefalexin; oral
2.4
14.4
355
2735
KFC00
NOMESCO Finland
Unilateral orchiectomy
20.0
14.4
21
11
N49.8
ICD-10 Finland
Inflammatory disorders of other specified male genital organs
+∞
13.6
13
*
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
6.7
13.5
34
54
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
4.9
13.4
44
97
R31
ICD-10 Finland
Unspecified haematuria
3.6
12.8
59
179
N02BE01
ATC
paracetamol; systemic, rectal
2.3
12.7
355
2794
N43.0
ICD-10 Finland
Encysted hydrocele
+∞
12.6
12
*
A46
ICD-10 Finland
Erysipelas
2.8
12.3
87
357
K60.3
ICD-10 Finland
Anal fistula
8.5
11.7
25
31
XJH00
NOMESCO Finland
Transanal ultrasonography
5.0
11.6
37
79
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.4
11.6
57
183
6000A
ICD-9 Finland
Hyperplasia of prostate[HYPERPLASIA PROSTATAE]
+∞
11.5
11
*
N48.1
ICD-10 Finland
Balanoposthitis
8.7
11.4
24
29
J01CA08
ATC
pivmecillinam; oral
4.7
11.3
38
86
N50.8
ICD-10 Finland
Other specified disorders of male genital organs
36.0
11.3
14
*
S97
ICPC
Chronic ulcer skin
4.5
11.3
40
96
N43.4
ICD-10 Finland
Spermatocele
18.4
10.8
16
9
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.9
10.8
44
121
N02AX02
ATC
tramadol; systemic, rectal
2.0
10.8
197
1265
ZZA00
NOMESCO Finland
Split skin graft
5.5
10.7
31
60
Y05
ICPC
Scrotum/testis sympt/compl other
12.4
10.4
18
15
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
6.5
10.3
26
42
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
10.3
126
684
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.2
10.1
114
595
SPAT1125
SPAT
Stoma care and guidance
11.0
9.9
18
17
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
2.8
9.8
64
248
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
3.0
9.7
56
201
R35
ICD-10 Finland
Polyuria
4.3
9.7
35
86
JHA00
NOMESCO Finland
Anal or perianal incision
7.4
9.6
22
31
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
9.5
58
215
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
5.6
9.5
27
51
S10
ICPC
Boil/carbuncle
4.2
9.5
35
88
KFH96
NOMESCO Finland
Other reconstructive operation on testis, epididymis or vas deferens
102.1
9.4
10
*
60740
ICD-8 Finland
Other disease of male genital organs, Seminal vesiculitis
+∞
9.4
9
*
7501
FHL
Testicular exploration (includes removal of biopsy, detorsion or appendix test)
+∞
9.4
9
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
9.0
9.4
19
22
C03CA01
ATC
furosemide; systemic
2.0
9.3
135
781
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
9.2
191
1261
N03AX16
ATC
pregabalin; oral
2.3
9.2
90
438
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
9.1
100
514
G04CB02
ATC
dutasteride; oral
3.9
9.1
37
102
S18
ICPC
Laceration/cut
1.9
9.0
172
1101
UJF32
NOMESCO Finland
Coloscopy
2.1
8.9
110
594
E0000UV
ATC
NA
2.0
8.8
151
926
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.6
8.7
38
111
N44
ICD-10 Finland
Torsion of testis
28.1
8.5
11
*
7502
FHL
Skrotum's incision revision or suturing
+∞
8.4
8
*
JFF23
NOMESCO Finland
Transversostomy
9.7
8.3
16
17
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.7
8.3
20
31
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.4
8.3
29
70
J01DA01
ATC
[U] cefalexin; systemic
1.8
8.2
255
1901
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
12.0
8.1
14
12
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.3
8.1
39
124
N05BA04
ATC
oxazepam; oral
2.2
8.1
93
486
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
8.0
145
902
B01AB05
ATC
enoxaparin; parenteral
2.0
7.9
113
642
A02BC02
ATC
pantoprazole; systemic
1.8
7.9
247
1837
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
7.8
74
352
JN2BD
NOMESCO Finland
Extensive CT exmaniation of lower part of abdomen
45.8
7.7
9
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.5
7.6
63
278
K61.0
ICD-10 Finland
Anal abscess
5.6
7.6
21
39
TQW11
NOMESCO Finland
Vacuum treatment of wound
6.3
7.6
19
31
N41.0
ICD-10 Finland
Acute prostatitis
10.3
7.6
14
14
SPAT1263
SPAT
Sampling
1.8
7.6
157
1021
N30.9
ICD-10 Finland
Cystitis, unspecified
6.2
7.5
19
32
N05AH04
ATC
quetiapine; oral
2.2
7.4
76
374
C07AB07
ATC
bisoprolol; oral
1.8
7.4
196
1375
J01FA06
ATC
roxithromycin; oral
1.8
7.4
149
957
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
7.0
7.4
17
25
M72.6
ICD-10 Finland
Necrotizing fasciitis
+∞
7.3
7
*
M54.5
ICD-10 Finland
Low back pain
1.9
7.3
120
718
J01AA02
ATC
doxycycline; systemic
1.7
7.3
296
2362
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
7.3
77
385
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.1
7.3
39
135
N41.1
ICD-10 Finland
Chronic prostatitis
7.5
7.2
16
22
B03XA02
ATC
darbepoetin alfa; parenteral
6.2
7.1
18
30
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
7.1
119
717
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
7.1
65
305
ZXA05
NOMESCO Finland
Left side
1.9
7.1
107
621
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
5.1
7.1
21
43
WX320
NOMESCO Finland
Spinalanesthesy
2.1
7.0
82
430
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.2
7.0
25
62
A28
ICPC
Limited function/disability NOS
2.4
7.0
60
273
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
7.0
57
252
R52.9
ICD-10 Finland
Pain, unspecified
3.1
6.8
35
118
L03.9
ICD-10 Finland
Cellulitis, unspecified
6.0
6.7
17
29
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
3.1
6.7
34
114
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.9
6.6
110
658
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
12.5
6.6
11
9
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
6.3
6.5
16
26
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.6
6.4
27
78
JN3AD
NOMESCO Finland
Abdominal CT examination
2.8
6.4
40
151
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.4
6.3
21
49
KED33
NOMESCO Finland
Transurethral incision of prostate
18.3
6.3
9
5
KFD70
NOMESCO Finland
Excision of lesion of skin of scrotum
+∞
6.3
6
*
N48.6
ICD-10 Finland
Induratio penis plastica
+∞
6.3
6
*
QBE05
NOMESCO Finland
Excision of sweat glands or sweat gland bearing skin from trunk
+∞
6.3
6
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.2
6.3
31
102
R53
ICD-10 Finland
Malaise and fatigue
2.1
6.3
73
383
A48.0
ICD-10 Finland
Gas gangrene
27.1
6.2
8
*
7451
FHL
Transurethral adenoma removal
27.1
6.2
8
*
G04CA52
ATC
tamsulosin and dutasteride; systemic
2.5
6.2
47
200
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
6.4
6.2
15
24
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
6.2
113
698
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.2
6.2
31
103
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.1
6.2
32
109
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
6.1
39
149
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
6.1
144
963
SPAT1254
SPAT
Administration of medicine
2.2
6.1
61
297
N05AX08
ATC
risperidone; systemic
2.7
6.1
40
158
M79.6
ICD-10 Finland
Pain in limb
1.8
6.1
118
743
R39.1
ICD-10 Finland
Other difficulties with micturition
5.3
6.1
17
33
N03AX12
ATC
gabapentin; oral
2.3
6.0
56
264
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026008) Bacteria identified in Urine by Culture
148
534
3.52
33.36
4.6
2.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
144
541
3.34
30.10
3.6
2.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
218
1039
2.96
30.09
6.3
4.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
115
458
2.97
21.04
2.5
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
209
1173
2.35
18.53
5.3
3.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
241
1475
2.23
16.97
6.5
3.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
305
2066
2.23
16.51
8.0
5.8
mmol/l
7.1
6.9
0.75
292
1957
(3002582) Erythrocytes [#/volume] in Urine
177
976
2.26
15.86
5.2
2.8
e6/l
127.4
130.4
0.01
142
768
(3044640) Blood type and Crossmatch panel - Blood
185
1048
2.22
15.44
3.3
2.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
284
1903
2.15
15.37
6.5
3.2
e6/l
30.3
2994.1
—
6
24
(3002032) Base excess in Venous blood by calculation
85
354
2.69
13.93
5.2
4.2
mmol/l
2.0
1.6
0.44
71
277
(3018095) Leukocytes [#/volume] in Urine
185
1086
2.12
13.80
5.7
3.2
e6/l
112.2
83.0
0.27
145
812
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
351
2612
2.17
13.73
10.1
8.4
u/l
78.2
81.1
0.73
327
2462
(36304419) Bacteria [Presence] in Urine
155
866
2.15
13.02
5.0
2.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
105
503
2.38
12.76
9.7
9.2
mmol/l
103.9
104.4
0.39
99
492
(3024561) Albumin [Mass/volume] in Serum or Plasma
228
1477
2.00
12.74
7.4
5.6
g/l
33.7
35.6
3.54
211
1371
(3030467) Casts [#/volume] in Urine by Automated count
158
896
2.12
12.72
5.2
2.8
e6/l
0.6
0.5
0.01
122
684
(3026782) Osmolality of Urine
124
640
2.25
12.65
4.4
2.6
mosm/kgh2o
576.1
595.7
0.42
112
542
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
150
836
2.14
12.62
3.6
2.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
107
523
2.33
12.39
4.0
2.5
e6/l
1.1
0.4
1.04
58
290
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
262
1794
1.97
12.36
8.0
7.4
umol/l
13.5
13.0
0.14
249
1714
(3013650) Neutrophils [#/volume] in Blood by Automated count
278
1947
1.97
12.23
10.6
10.1
e9/l
5.0
4.3
2.99
248
1701
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
113
583
2.21
11.43
2.2
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
123
660
2.15
11.26
4.3
2.3
e6/l
3.2
3.3
0.09
115
587
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
238
1613
1.91
11.23
11.7
8.3
mmol/l
1.2
1.2
0.63
206
1375
(3022948) Iron [Moles/volume] in Serum or Plasma
105
536
2.22
10.86
3.4
2.8
umol/l
11.8
13.7
1.67
97
505
(3000991) Gas panel - Venous blood
77
348
2.43
10.54
10.1
11.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
220
1479
1.87
10.42
10.8
7.7
mmol/l
1.2
1.2
1.15
201
1359
(3012095) Magnesium [Moles/volume] in Serum or Plasma
118
641
2.10
10.38
4.1
3.8
mmol/l
0.8
0.8
2.78
111
610
(46235355) HIV 1 and 2 tests - Meaningful Use set
106
555
2.16
10.25
2.2
1.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
106
555
2.16
10.25
3.9
2.4
e6/l
1.4
0.8
0.90
58
321
(3013115) Eosinophils [#/volume] in Blood
248
1739
1.85
10.21
6.8
6.6
e9/l
0.2
0.2
1.63
221
1536
(3022217) INR in Platelet poor plasma by Coagulation assay
97
491
2.21
10.20
24.7
24.6
inr
1.3
1.4
0.10
17
67
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
59
242
2.63
9.87
2.4
1.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
17
29
6.03
9.65
1.8
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
218
1493
1.82
9.49
12.1
9.5
inr
1.4
1.3
0.69
49
407
(3004789) Transferrin [Mass/volume] in Serum or Plasma
97
505
2.14
9.46
3.5
2.7
g/l
2.2
2.3
0.17
91
472
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
134
787
1.96
9.40
2.6
2.0
mg/l
3.3
3.0
0.51
123
675
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
92
475
2.15
9.15
3.5
2.8
%
23.6
24.3
0.13
81
426
(3006315) Basophils [#/volume] in Blood
239
1699
1.78
9.05
6.7
6.2
e9/l
0.0
0.0
0.11
214
1476
(3019198) Lymphocytes [#/volume] in Blood
244
1747
1.78
9.00
6.5
6.3
e9/l
1.9
1.9
0.01
223
1542
(3019150) Specific gravity of Urine by Refractometry
118
676
1.98
8.84
4.2
3.2
kg/l
1.0
1.0
1.27
17
86
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
82
410
2.20
8.83
2.0
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
164
1048
1.84
8.81
3.6
3.0
u/l
61.0
57.9
0.40
154
988
(3003396) Base excess in Arterial blood by calculation
88
454
2.14
8.75
10.0
10.9
mmol/l
1.3
0.9
0.48
69
349
(3001604) Monocytes [#/volume] in Blood
237
1693
1.76
8.73
6.7
6.2
e9/l
0.6
0.6
0.45
214
1464
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
82
412
2.19
8.72
2.0
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
283
2137
1.75
8.49
6.0
3.5
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
87
456
2.10
8.29
10.0
10.9
kpa
11.1
12.1
1.08
82
438
(3022096) Basophils/100 leukocytes in Blood
218
1543
1.74
8.13
7.1
6.2
%
0.6
0.7
0.78
211
1462
(3021901) Oxygen saturation in Capillary blood
23
60
3.97
8.06
2.4
3.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
105
600
1.95
7.85
1.9
1.7
nmol/l
1192.2
1115.4
0.25
80
475
(3027945) Reticulocytes/100 erythrocytes in Blood
82
429
2.09
7.83
3.3
2.4
%
1.9
1.8
0.16
75
385
(3035350) Ketones [Presence] in Urine by Test strip
209
1475
1.72
7.79
4.7
2.8
estimate
0.0
0.0
0.00
27
240
(3006504) Eosinophils/100 leukocytes in Blood
222
1595
1.71
7.73
7.6
6.2
%
2.6
3.0
2.64
216
1503
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
42
165
2.69
7.65
2.4
2.1
ug/l
4.0
0.9
0.74
36
146
(3002030) Lymphocytes/100 leukocytes in Blood
228
1655
1.70
7.61
7.7
6.3
%
25.2
26.6
0.93
220
1557
(42870588) Differential panel, method unspecified - Blood
173
1165
1.74
7.58
6.7
6.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
191
1323
1.72
7.56
2.2
2.0
pmol/l
86.7
90.7
0.67
112
759
(3009261) Glucose [Presence] in Urine by Test strip
210
1495
1.70
7.51
4.7
2.8
estimate
0.1
0.0
0.48
24
233
(3019069) Monocytes/100 leukocytes in Blood
222
1607
1.69
7.44
8.3
6.6
%
8.8
9.1
0.58
216
1522
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
167
1119
1.74
7.42
2.6
2.2
nmol/l
69.7
72.8
0.64
145
990
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
84
453
2.03
7.38
4.3
4.3
u/l
221.4
247.6
1.62
79
429
(3018010) Neutrophils/100 leukocytes in Blood
224
1628
1.68
7.37
7.3
6.1
%
58.8
57.7
0.60
216
1548
(40758558) Short blood count panel - Blood
132
829
1.81
7.31
7.1
7.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
407
3488
1.92
7.29
29.7
14.8
mg/l
35.6
28.2
3.53
363
2766
(3021601) Nitrite [Presence] in Urine by Test strip
207
1479
1.68
7.23
6.3
3.8
estimate
0.0
0.0
0.00
29
256
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
173
1180
1.71
7.17
3.8
3.8
u/l
34.1
38.3
0.51
164
1123
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
36
137
2.75
6.97
2.7
2.8
u/ml
0.3
0.3
0.68
20
71
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
155
1037
1.72
6.83
2.5
2.2
u/l
348.0
342.5
0.01
145
965
(3035637) Corticotropin [Mass/volume] in Plasma
17
40
4.37
6.80
2.5
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
73
385
2.05
6.80
2.3
2.6
g/l
0.2
0.2
0.43
65
352
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
73
3.40
6.78
1.5
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
73
3.40
6.78
1.5
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
113
692
1.82
6.75
3.9
2.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
89
3.15
6.72
2.3
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
301
2405
1.64
6.53
4.5
3.7
mm/h
14.5
11.9
1.57
282
2222
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
56
271
2.20
6.50
3.2
3.2
ml/min/173m2
59.9
69.6
1.18
28
110
(3028707) Methadone [Presence] in Urine by Screen method
22
65
3.50
6.49
6.1
3.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
139
914
1.72
6.48
7.1
4.6
ph
7.4
7.4
0.72
26
156
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
151
1018
1.69
6.41
3.3
3.1
ng/l
1693.2
1618.1
0.09
138
878
(3029937) Albumin [Presence] in Urine by Test strip
123
788
1.75
6.26
5.0
3.0
estimate
0.0
0.0
0.68
26
224
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
46
208
2.34
6.26
1.7
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
349
2914
1.66
6.18
4.2
3.5
mu/l
1.9
2.0
0.26
322
2637
(3020630) Protein [Mass/volume] in Serum or Plasma
57
288
2.11
5.94
1.3
3.2
g/l
65.5
66.5
0.33
47
264
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
164
1150
1.64
5.91
5.0
2.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
280
2241
1.57
5.69
3.3
2.9
pmol/l
15.0
14.8
0.34
248
2016
(3009508) Creatinine [Moles/volume] in Urine
164
1164
1.61
5.57
4.6
3.4
mmol/l
7.8
8.8
1.94
136
991
(3001122) Ferritin [Mass/volume] in Serum or Plasma
165
1174
1.61
5.54
3.6
2.6
ug/l
175.3
218.4
0.91
153
1079
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
53
273
2.05
5.25
2.2
2.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
146
1020
1.61
5.24
4.4
3.6
mmol/l
2.3
2.3
0.19
128
897
(3011288) Drugs identified in Urine by Screen method
29
117
2.57
5.05
5.9
3.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
185
1381
1.54
4.94
4.5
3.5
ng/l
58.7
53.1
0.10
143
989
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
107
701
1.67
4.93
4.8
3.8
ng/l
262.6
602.8
1.19
88
577
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
105
685
1.68
4.91
1.7
1.7
mg/l
1.7
1.4
0.16
82
517
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
20
67
3.07
4.88
1.4
1.4
u/ml
124.3
89.6
—
6
13
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
56
304
1.95
4.81
2.3
2.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
51
268
2.01
4.80
6.8
6.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
80
2.83
4.67
1.4
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
39
187
2.18
4.66
1.6
1.8
g/l
1.5
1.5
0.01
34
164
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
104
686
1.65
4.65
1.8
1.7
pmol/l
443.2
16525107.8
0.79
86
587
(3017143) Hepatitis C virus Ab [Presence] in Serum
72
429
1.79
4.64
2.0
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
65
377
1.83
4.57
1.2
1.3
titre
200.0
315.2
—
9
66
(4198724)
10
21
4.84
4.55
2.4
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
44
225
2.05
4.46
1.2
2.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
64
373
1.82
4.43
5.0
3.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
21
78
2.77
4.30
1.5
1.2
u/ml
363.3
207.1
0.84
13
43
(3003327) Ova and parasites identified in Stool by Light microscopy
22
84
2.69
4.29
1.8
1.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
409
3675
1.64
4.25
32.4
17.4
mmol/l
4.0
4.0
0.30
398
3583
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
69
417
1.76
4.24
2.1
3.0
umol/l
11.9
10.3
0.15
62
375
(3024928) Oxygen saturation in Venous blood
22
86
2.63
4.11
4.0
3.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
406
3655
1.61
4.03
32.5
17.3
mmol/l
139.1
139.6
3.91
395
3566
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
70
432
1.72
3.99
1.9
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
297
2511
1.45
3.98
4.5
3.3
u/l
66.3
60.7
0.46
278
2361
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
43
229
1.96
3.92
1.7
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
59
349
1.78
3.90
2.3
2.3
ug/l
6.7
10.3
0.89
51
310
(3012516) Albumin [Mass/volume] in Urine
144
1063
1.50
3.89
4.4
3.4
mg/l
83.3
220.7
0.85
103
758
(40768804) Tissue Pathology biopsy report
147
1090
1.50
3.89
2.4
2.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
192
1502
1.45
3.87
12.5
9.1
e9/l
0.0
0.0
0.84
150
1226
(3048689) Calprotectin [Mass/mass] in Stool
59
350
1.78
3.86
2.8
2.6
ug/g
192.5
153.9
0.36
50
292
(40761535) Cells panel - Urine sediment
48
267
1.88
3.85
5.1
3.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
151
1129
1.48
3.83
5.6
4.1
mg/mmol
11.1
10.9
0.02
104
800
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
41
217
1.97
3.81
15.4
16.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
32
156
2.12
3.70
2.5
2.6
ug/l
351.1
606.0
0.42
32
151
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
22
91
2.48
3.69
8.5
5.8
iu/ml
147.4
2154.0
—
5
14
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
28
131
2.21
3.59
2.1
1.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
55
327
1.77
3.58
3.0
2.5
e9/l
73.8
70.4
0.25
35
253
(44816559) Phosphatidylethanol [Mass/volume] in Blood
21
87
2.48
3.52
1.2
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
19
75
2.59
3.50
1.4
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
40
218
1.91
3.43
6.3
3.6
mmol/l
1.2
1.2
0.05
35
197
(3049717) Cytology report of Urine Cyto stain
29
141
2.12
3.39
2.6
2.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
102
2.32
3.34
3.3
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
330
2895
1.42
3.29
31.2
17.6
%
14.2
13.7
5.48
324
2812
(3021960) Folate [Moles/volume] in Serum or Plasma
103
735
1.51
3.23
1.7
1.6
nmol/l
15.1
19.1
3.53
91
627
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
144
2.08
3.22
2.4
2.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
52
314
1.73
3.22
2.8
3.0
ng/l
198.9
225.0
0.25
45
278
(3011648) Oxygen content in Venous blood
11
33
3.39
3.21
2.5
1.5
%
9.9
11.4
0.73
11
33
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
254
2140
1.38
3.17
2.8
2.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
27
132
2.11
3.13
5.7
2.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
19
80
2.43
3.10
1.5
4.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
379
3425
1.45
3.08
4.9
4.3
mmol/l
6.4
6.1
2.04
352
3120
(40768446) Kidney Pathology biopsy report
7
12
5.90
3.03
1.3
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
81
2.40
3.02
1.6
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
51
2.80
3.01
1.1
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
276
2370
1.37
3.00
4.7
4.1
ug/l
2.9
2.1
0.62
252
2086
(1616796) Gas panel - Central venous blood
18
76
2.42
2.92
5.9
3.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
417
3853
1.51
2.89
13.9
10.3
u/l
29.7
31.7
1.39
407
3728
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
55
348
1.65
2.89
2.2
2.6
u/l
27.4
181.3
0.59
48
302
(3002256) Pathology report gross observation
55
348
1.65
2.89
1.6
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
9
6.73
2.87
1.2
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
77
2.39
2.85
1.2
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
365
3295
1.41
2.83
7.3
5.7
mmol/mol
42.2
40.3
2.32
335
3065
(40761511) CBC panel - Blood by Automated count
404
3715
1.47
2.82
24.6
13.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
24
117
2.10
2.82
2.7
2.2
ug/min
67.5
117.4
0.67
19
70
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
84
2.31
2.80
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
84
2.31
2.80
1.3
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
129
988
1.41
2.78
3.7
2.8
umol/l
395.6
6364.9
3.17
113
873
(3000764) Benzodiazepines [Presence] in Urine
32
175
1.89
2.75
5.0
2.7
—
—
—
0
0
(3020891) Body temperature
31
168
1.90
2.74
8.3
4.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
85
2.28
2.74
1.3
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
33
183
1.86
2.72
3.1
2.5
—
—
—
0
0
(3044889) 12 lead EKG panel
287
2504
1.35
2.69
4.3
3.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
16
67
2.43
2.66
1.4
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
98
720
1.45
2.64
6.4
4.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
74
2.34
2.60
1.4
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
30
164
1.88
2.59
5.2
2.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
32
179
1.84
2.58
5.0
2.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
105
786
1.43
2.56
4.9
2.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
32
180
1.83
2.54
5.3
2.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
27
144
1.93
2.51
6.0
3.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
57
2.50
2.47
1.3
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
13
51
2.59
2.46
1.8
1.3
e6/l
342.0
1806.7
—
8
36
(40768443) Skin Pathology biopsy report
23
117
2.01
2.44
1.1
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
23
117
2.01
2.44
1.4
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
367
3348
1.37
2.43
23.8
13.0
ml/min/173m2
83.1
82.5
0.16
314
2801
(3009343) pH of Capillary blood
43
268
1.66
2.41
4.5
4.0
ph
7.4
7.4
—
7
22
(3027944) Amphetamines [Presence] in Urine
31
176
1.81
2.40
5.0
2.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
133
1.93
2.35
1.1
3.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
133
1.93
2.35
1.1
3.0
g/l
7.3
7.0
0.33
18
99
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
133
1.93
2.35
1.1
3.0
g/l
4.4
3.9
0.46
18
94
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
126
1.95
2.35
1.1
3.2
g/l
3.0
3.1
0.27
18
96
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
78
2.22
2.33
1.2
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
41
256
1.66
2.29
4.4
4.0
mmol/l
2.3
1.6
0.65
32
200
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
53
2.49
2.29
1.3
1.5
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
5
9
5.60
2.22
1.6
2.2
%
5.6
16.0
—
5
9
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
122
1.93
2.20
1.1
3.1
g/l
11.4
10.9
0.13
18
102
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
67
2.28
2.19
1.3
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
87
2.11
2.19
1.9
1.6
ug/g
260.5
264.2
0.03
13
51
(3025941) Bacteria identified in Stool by Culture
28
159
1.81
2.18
1.4
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
29
167
1.78
2.16
2.2
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
36
222
1.67
2.12
2.9
3.0
e9/l
4.4
4.3
0.11
28
173
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
81
599
1.42
2.11
3.6
3.4
mmol/l
2.5
2.4
0.49
69
524
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
5
10
5.04
2.07
1.6
2.2
%
42.6
23.6
—
5
10
(3021879) Hepatitis B virus core Ab [Presence] in Serum
44
288
1.58
2.06
1.5
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
20
3.53
2.06
1.7
4.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
63
2.26
2.02
2.3
3.5
%
57.7
58.0
0.02
14
63
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
44
2.53
2.02
2.0
3.5
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
26
3.11
2.02
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
26
3.11
2.02
1.0
1.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
22
119
1.89
2.00
1.7
4.2
mg/l
60.8
57.7
0.06
16
101
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
22
119
1.89
2.00
1.6
4.2
mg/l
30.3
37.3
0.57
16
102
(3007164) IgA [Mass/volume] in Serum or Plasma
77
573
1.41
1.94
1.3
1.4
g/l
3.8
2.9
1.21
50
373
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
11
4.58
1.94
1.0
1.3
—
—
—
0
0
(4027681)
6
16
3.78
1.94
1.2
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
80
601
1.39
1.91
1.2
1.2
u/ml
0.6
1.3
3.05
19
162
(3021788) Differential panel - Synovial fluid
12
52
2.34
1.89
1.2
1.5
—
—
—
0
0
(4062490)
8
28
2.89
1.87
1.3
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
78
587
1.39
1.85
3.1
2.1
%
1.9
1.6
1.69
71
512
(3002179) Metamyelocytes/100 leukocytes in Blood
38
247
1.58
1.85
5.0
3.7
%
0.5
0.5
0.05
12
65
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
40
2.53
1.84
3.4
3.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
20
108
1.89
1.84
8.4
11.9
mmol/l
1.4
1.4
0.14
15
91
(21494755) Public health laboratory ask at order entry panel
26
421
0.60
1.82
1.5
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
29
2.79
1.80
1.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
10
41
2.47
1.76
1.9
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
41
275
1.54
1.75
5.4
3.8
%
0.6
1.0
0.61
19
85
(3007461) Platelets [#/volume] in Blood
426
4049
1.36
1.65
38.3
20.5
e9/l
243.1
235.9
1.27
416
3931
(3021440) Promyelocytes/100 leukocytes in Blood
38
255
1.53
1.63
4.6
3.8
%
0.2
0.2
0.16
19
76
(3033799) Differential panel - Peritoneal fluid
5
14
3.60
1.62
2.2
3.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
426
4052
1.36
1.61
38.0
20.4
pg
30.3
30.6
1.76
420
3983
(21494434) Karyotype in Bone marrow
10
43
2.35
1.61
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
359
3339
1.27
1.61
28.3
15.5
%
40.4
41.3
1.04
263
2466
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
212
1860
1.24
1.60
4.2
3.5
%
22.0
21.6
0.13
93
780
(3024731) MCV [Entitic volume]
426
4053
1.36
1.60
38.0
20.4
fl
90.7
91.0
0.48
420
3985
(3026361) Erythrocytes [#/volume] in Blood
426
4053
1.36
1.60
38.2
20.5
e12/l
4.5
4.7
5.27
416
3924
(3000963) Hemoglobin [Mass/volume] in Blood
426
4054
1.36
1.59
38.4
20.6
g/l
135.7
142.0
9.24
419
3984
(3010813) Leukocytes [#/volume] in Blood
426
4054
1.36
1.59
38.3
20.5
e9/l
7.7
6.8
5.74
414
3930
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
20
3.02
1.58
2.8
2.4
—
—
—
0
0
(44813793)
6
20
3.02
1.58
1.3
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
60
445
1.40
1.56
1.4
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
85
1.91
1.56
1.9
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
22
130
1.72
1.55
1.5
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
33
2.45
1.54
1.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
33
2.45
1.54
2.0
2.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
33
2.45
1.54
1.9
3.3
—
—
—
0
0
(4281824)
5
15
3.36
1.52
1.4
1.7
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
27
2.61
1.52
1.6
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
51
2.18
1.51
10.7
2.8
—
—
—
0
0
(3035880) pH of Pleural fluid
6
21
2.88
1.51
1.2
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
58
2.10
1.50
1.2
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
26
163
1.63
1.49
1.1
1.2
—
12.4
—
0
5
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
37
2.46
1.48
1.4
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
87
1.87
1.47
1.5
1.7
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
5
16
3.15
1.44
17.4
11.3
mmol/l
0.8
0.6
—
5
16
(3042733) HLA Ab [Presence] in Serum
5
16
3.15
1.44
6.0
4.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
22
2.75
1.44
1.3
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
22
2.75
1.44
1.3
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
22
134
1.67
1.41
1.5
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
55
410
1.38
1.41
1.6
1.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
10
46
2.20
1.40
2.0
1.3
e6/l
9255.8
112748.3
—
5
29
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
25
158
1.61
1.40
2.2
3.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
20
119
1.71
1.40
1.1
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
29
2.43
1.39
1.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
23
2.63
1.37
5.7
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
23
2.63
1.37
5.7
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
15
82
1.86
1.37
5.9
4.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
9
42
2.16
1.34
1.0
1.3
iu/l
13.4
6.0
—
9
30
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
380
3587
1.25
1.33
4.8
4.3
mmol/l
4.4
4.5
0.59
347
3345
(3051611) Lipemic interference index of Serum or Plasma
9
43
2.11
1.31
6.0
4.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
43
2.11
1.31
1.9
2.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
49
364
1.38
1.29
1.7
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
18
2.80
1.29
1.0
1.0
iu/ml
124.2
181.6
—
5
18
(3045414) Leukocytes [Presence] in Urine
19
115
1.68
1.26
2.9
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
36
2.24
1.24
1.3
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
45
2.02
1.24
1.6
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
63
1.93
1.23
2.2
3.3
e9/l
3.9
4.5
0.31
12
63
(3003694) ABO and Rh group [Type] in Blood
110
922
1.25
1.23
1.4
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
37
2.18
1.22
1.4
1.5
nmol/l
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
1.0
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
33
232
1.45
1.18
7.1
2.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
50
2.02
1.17
1.3
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
54
415
1.34
1.17
13.5
7.5
—
—
—
0
0
(3013512) EKG study
116
984
1.23
1.16
5.3
3.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
15
87
1.75
1.16
1.9
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
72
1.83
1.16
1.3
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
65
1.87
1.14
3.3
2.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
33
234
1.44
1.14
5.5
3.9
%
0.0
0.0
0.80
11
66
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
384
3650
1.23
1.14
5.2
4.7
mmol/l
2.7
2.7
0.39
353
3371
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
376
3567
1.22
1.13
4.8
4.2
mmol/l
1.2
1.3
5.32
346
3289
(3039162) Centromere protein B Ab [Units/volume] in Serum
7
30
2.35
1.12
1.3
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
73
1.80
1.12
1.4
1.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
67
535
1.29
1.11
2.2
2.3
nmol/l
12.0
13.8
1.19
59
479
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
1.2
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
41
1.97
1.09
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
41
1.97
1.09
2.0
2.4
—
—
—
0
0
(3019225) pH of Specimen
42
314
1.37
1.09
6.6
4.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
59
1.88
1.08
1.5
2.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
74
1.78
1.07
1.2
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
53
414
1.31
1.04
1.3
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
22
2.29
1.03
6.6
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
22
2.29
1.03
6.6
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
5
22
2.29
1.03
1.0
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
48
1.89
1.01
1.4
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
48
1.89
1.01
1.2
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
35
2.01
1.00
7.0
3.9
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
35
2.01
1.00
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
30
215
1.42
1.00
1.2
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
25
173
1.47
0.99
1.4
1.2
—
30.2
—
0
9
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
365
3471
1.19
0.98
4.5
3.9
mmol/l
1.5
1.4
2.09
336
3191
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
19
124
1.55
0.98
1.2
1.2
iu/ml
84.5
121.7
—
6
46
(21494890) Protein electrophoresis panel - 24 hour Urine
7
36
1.96
0.97
1.0
3.0
—
—
—
0
0
(4035726)
37
278
1.36
0.95
1.3
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
93
1.63
0.95
1.9
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
134
1.51
0.93
1.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
55
1.83
0.92
4.1
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
63
1.76
0.90
1.8
2.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
43
1.87
0.87
1.4
1.8
pg
33.5
33.3
—
8
43
(44790048)
8
44
1.83
0.86
1.6
1.7
—
—
—
0
0
(44790049)
8
44
1.83
0.86
1.6
1.7
—
—
—
0
0
(44806118)
8
44
1.83
0.86
1.6
1.7
—
—
—
0
0
(44790047)
8
44
1.83
0.86
1.6
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
104
1.56
0.85
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
45
1.79
0.84
1.4
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
12
73
1.66
0.82
1.2
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
32
1.89
0.82
1.2
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
47
1.71
0.81
6.4
4.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
47
1.71
0.81
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
47
1.71
0.81
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
90
1.57
0.79
1.3
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
34
1.77
0.76
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
(4268621)
6
34
1.77
0.76
3.3
2.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
12
75
1.61
0.75
8.6
4.8
mmol/l
3.8
2.2
—
7
48
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
75
1.61
0.75
3.7
2.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
55
1.65
0.74
1.1
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
18
125
1.46
0.73
3.8
4.6
g/l
0.6
0.2
—
8
77
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.4
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
76
1.59
0.72
2.2
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
52
428
1.24
0.72
1.3
1.2
iu/ml
17.0
45.7
2.03
24
131
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
26
1.93
0.71
1.0
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
28
213
1.33
0.70
5.3
3.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
157
0.63
0.70
1.8
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
49
407
1.23
0.64
1.3
1.2
u/ml
13.2
11.9
0.05
19
167
(3044290) Cell count panel - Cerebral spinal fluid
10
63
1.60
0.62
1.0
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
16
115
1.40
0.57
7.8
3.9
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
37
1.63
0.55
1.3
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.2
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
40
1.51
0.51
1.3
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
125
1360
0.89
0.50
3.3
2.7
—
—
—
0
0
(4146454)
6
41
1.47
0.50
2.7
2.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
46
393
1.19
0.48
4.8
4.2
%
30.6
29.9
0.14
26
264
(3045424) Erythrocytes [Presence] in Urine
7
49
1.43
0.46
1.7
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
49
1.43
0.46
2.1
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
50
1.41
0.45
1.7
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
69
1.46
0.44
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
148
1.30
0.44
2.7
2.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
16
122
1.32
0.43
6.4
3.0
mg/l
1.9
1.6
0.70
16
112
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
40
342
1.18
0.42
3.6
5.0
ug/l
22.9
40.5
0.29
34
297
(3023410) Appearance of Cerebral spinal fluid
5
33
1.52
0.41
1.4
1.5
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.3
—
3.2
—
0
6
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
16
0.00
0.41
0.0
1.4
—
156.5
—
0
16
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.7
—
207.1
—
0
17
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
2.4
2.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
2.4
2.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
2.4
2.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
18
0.00
0.40
0.0
1.1
—
12.9
—
0
11
(3000093) Morphology [Interpretation] in Blood Narrative
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
97
891
1.11
0.38
1.7
1.7
mmol/l
1.6
1.5
0.67
83
757
(3001019) Free T4 and TSH panel - Serum or Plasma
8
115
0.69
0.37
2.1
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
25
298
0.83
0.36
1.6
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
42
1.43
0.35
2.0
4.2
—
—
—
0
0
(4010399)
29
246
1.19
0.35
1.2
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
45
1.34
0.34
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
141
1332
1.08
0.31
3.0
2.5
ug/l
1.0
0.7
0.60
87
781
(4306422)
7
54
1.30
0.30
1.7
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
75
1.34
0.30
1.5
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
66
1.22
0.27
1.9
1.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
5
39
1.28
0.23
1.4
1.4
e6/l
473430.0
74771.9
—
5
33
(3022806) Fractional oxyhemoglobin in Capillary blood
5
40
1.25
0.22
2.0
1.6
%
89.0
87.9
—
5
40
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
10
0.00
0.21
0.0
1.3
—
89.2
—
0
10
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
18
154
1.18
0.21
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
101
0.79
0.21
1.4
1.5
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
8.0
—
0
5
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(4133840)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
48
1.25
0.20
1.2
1.0
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
0.5
—
0
6
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
24
212
1.14
0.20
1.6
1.8
nmol/l
45.3
37.5
0.82
24
203
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
51
1.18
0.19
1.7
1.1
—
—
—
0
0
(1002224) Polysomnography panel
19
165
1.16
0.19
1.1
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
52
1.16
0.19
1.2
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
32
352
0.90
0.18
1.7
1.8
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
61
1.15
0.17
6.0
5.0
umol/l
236.4
340.5
—
7
53
(4094501)
12
101
1.19
0.16
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
13
113
1.15
0.13
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
230
0.91
0.12
1.5
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
45
1.11
0.10
3.6
3.8
nmol/l
2.3
7.0
—
5
45
(3000492) Spirometry study
37
390
0.94
0.09
1.4
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
146
1.10
0.08
1.5
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
68
1.03
0.08
1.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
34
327
1.04
0.05
1.4
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
10
97
1.03
0.00
1.9
2.0
mg/l
11.9
12.5
—
10
91
(3008898) HLA-B27 [Presence]
8
89
0.90
0.00
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
66
0.91
0.00
2.0
2.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.8
—
9.7
—
0
8
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806420)
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
9
0.00
0.00
0.0
2.6
—
3240.3
—
0
9
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
1.5
—
1.3
—
0
6
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
1.2
—
0
6
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
110.3
—
0
5
(3010370) Gastrin [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
12.5
—
0
6
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
8
79
1.01
0.00
2.6
4.5
u/ml
50.3
283.4
—
8
73
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
12
120
1.00
0.00
9.9
11.8
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.8
—
85.3
—
0
8
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint N14_INFLAMALEGEN and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| N14_INFLAMALEGEN | 2.512 [2.08, 3.03] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.029 |
During the follow-up period (1.1.1998 — 31.12.2019), 722 out of 2965 males with N14_INFLAMALEGEN died.
Mortality risk
Mortality risk for people of age
years, who have N14_INFLAMALEGEN.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.608% |
| 5 | No data | 3.211% |
| 10 | No data | 7.611% |
| 15 | No data | 14.331% |
| 20 | No data | 23.47% |
Relationships between endpoints
↥Index endpoint: N14_INFLAMALEGEN – Inflammatory disorders of male genital organs, not elsewhere classified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data